FindTrial
Sign In

A survey of infusion methods of antimicriobial drugs among hospitalized patients in Chinese Intensive Care Units

A survey of infusion methods of antimicriobial drugs among hospitalized patients in Chinese Intensive Care Units

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049979
Enrollment
Unknown
Registered
2021-08-15
Start date
2021-09-20
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection disease

Interventions

case series:none

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: All ICU inpatients on September 20, 2021.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
28-day all-cause mortality;—

Countries

China

Contacts

Public ContactWang Hao

Qilu Hospital of Shandong University

wanghao34@126.com+86 18560081013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026